Effects of Photodynamic Therapy Using 5 -Aminolevulinic Acid (ALA) Loaded Acrylic Nanoparticles (ANPs) on HaCaT Cells
DOI: https://doi.org/10.2147/ccid.s458525
2024-05-31
Clinical Cosmetic and Investigational Dermatology
Abstract:Kang Ge, 1, 2 Yilu Zhao, 2, 3 Xiao Liu, 4 Ruzhi Zhang 5 1 Jiaxing Key Discipline of Medicine --Dermatology and Venereology, The Affiliated Hospital of Jiaxing University, The First Hospital of Jiaxing, Jiaxing, Zhejiang, People's Republic of China; 2 Department of Dermatology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, People's Republic of China; 3 Department of Dermatology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, People's Republic of China; 4 School of Materials Science and Engineering, Changzhou University, Changzhou, Jiangsu, People's Republic of China; 5 Department of Dermatology and STD, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, People's Republic of China Correspondence: Ruzhi Zhang, Department of Dermatology and STD, The Second Affiliated Hospital of Wannan Medical College, Wuhu, Anhui, 241001, People's Republic of China, Tel +8618761161826, Email Objective: ALA-PDT (5-aminolevulinic acid photodynamic therapy) is a central modality in the treatment of skin diseases. Increasing the bioavailability of ALA remains a critical issue. With this in mind, our study explores a novel route of ALA delivery by loading acrylic nanoparticles (ANPs). Methods: ALA-ANPs were synthesized by emulsion polymerisation and characterised by scanning electron microscopy (SEM), transmission electron microscopy (TEM) and nanoparticle tracking analysis (NTA). The effects of ALA-ANPs on HaCaT cell line were evaluated, including characteristics, morphological changes, protoporphyrin IX (PpIX) fluorescence kinetics, reactive oxygen species (ROS) levels, mitochondrial membrane potential and ki67 expression in these cells. Results: The ANPs had uniform sizes, smooth surfaces and excellent light transmittance, with diameters of 150– 200 nm. In contrast, the ALA - ANPs had uneven surfaces and poor light transmittance, with diameters of 220– 250 nm. During 12 hours of co-incubation of HaCaT cells with ALA, the intracellular accumulation of PpIX increased over time. Notably, after 6 hours of incubation, PpIX levels induced by 1.81 mg/mL ALA-ANPs exceeded those induced by 1.0 mM ALA ( p < 0.01 ). CCK-8 results showed a positive correlation between PDT-induced inhibition of HaCaT cell proliferation and ALA concentration when ALA concentration remained below 2.0 mM. Compared to the 1.0 mM ALA group, the 1.81 mg/mL ALA-ANPs group showed decreased mitochondrial membrane potential, ki67 immunofluorescence intensity and cell proliferation. In contrast, ROS levels were significantly increased in the 1.81 mg/mL ALA-ANPs group (p < 0.01). Conclusion: Loading ANPs provide improved stability and potency for ALA. The ALA-ANPs-PDT approach has superior inhibitory effects on HaCaT proliferation in vitro. Keywords: 5-aminophenolvalic acid, ALA, acrylate nanoporous, photodynamic therapy Photodynamic therapy (PDT), a clinical modality, uses visible light to activate photosensitizers (PSs) that induce a cascade of photochemical reactions within targeted cells. 1 ALA and MAL are the most commonly used PSs. ALA acts as a second generation porphyrin photosensitiser, acting as a precursor to protoporphyrin IX (PpIX) within the haem biosynthetic pathway. 2 When ALA is converted to PpIX, which has robust photosensitivity and accumulates preferentially in proliferating cells, excitation with light of a specific wavelength produces abundant singlet oxygen and free radicals, resulting in apoptosis and necrosis of these unwanted cells. 3 Currently, the bioavailability of ALA often falls short of the desired therapeutic effect due to its polarity and the influence of physiological pH. 4 To overcome these limitations, nanoporous drug delivery systems such as liposomes, chitosan nanoparticles (NP) and polylactic glycolate (PLGA) have been investigated. 5 The liposome delivery system offers the advantage of encapsulating hydrophilic drugs such as ALA in its aqueous core. 6 Polymeric nanoparticles show potential as ALA carriers due to their smaller pore size, which allows for easier epidermal penetration. 7 Nanoparticle-loaded ALA has shown increased PpIX fluorescence and greater photocytotoxicity compared to free ALA at equivalent concentrations. 8 The polymeric micellar system allows for a steady and continuous release of ALA while enhancing cellular uptake. 9 ALA-loaded nanofibres have also shown potential for drug delivery as a substrate for PpIX production. 10 However, these NP systems have certain limitations, including instability, potential drug leakage from capsule -Abstract Truncated-
dermatology